The value of serum bcl-2 levels in advanced epithelial ovarian cancer

By Tas Faruk   Duranyildiz Derya   Oguz Hilal   Camlica Hakan   Yasasever Vildan   Topuz Erkan  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 213-217

Humana Press, Inc

Access to resources Recommend Favorite

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up

By Fujiwara K.   Sakuragi N.   Suzuki S.   Yoshida N.   Maehata K.   Nishiya M.   Koshida T.   Sawai H.   Aotani E.   Kohno I.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 637-643

Elsevier

Access to resources Recommend Favorite

Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up

By Landys K.   Persson S.   Kovařík J.   Hultborn R.   Holmberg E.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 27-33

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of p53 and Bcl-2 Expression as Prognostic Markers in Invasive Cervical Carcinoma Stage IIb/III Patients Treated by Radiotherapy

By Jain D.   Srinivasan R.   Patel F.D.   Kumari Gupta S.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 22-28

Academic Press

Access to resources Recommend Favorite

Prognostic Value of Mdm2, p53 and p16 in Patients with Astrocytomas

By Ranuncolo Stella   Varela Mirta   Morandi Ana   Lastiri José   Christiansen Silvia   Bal de Kier Joffé Elisa   Pallotta María   Puricelli Lydia  

Journal of Neuro-Oncology, Vol. 68, Iss. 2, 2004-06 ,pp. : 113-121

Springer Publishing Company

Access to resources Recommend Favorite